The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

The Food & Beverage sector maintained its leadership position with a 22% share of total ad volumes, followed by the personal ...

Back in favour as a trendy option, glass is the ideal packaging choice for the circular economy. Glass is supported by an established and efficient recycling systems. Driving this momentum is a ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain s GSK and Germany s CureVac $740 ...

The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the ...

Shares of behavioral health company LifeStance Health (NASDAQ:LFST) jumped 11% in the afternoon session after the company ...

With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

Donald Trump’s plan to force down drug prices in the United States by demanding pharmaceutical companies raise prices in ...

The complex settlement, which hands payouts and royalties to CureVac and partner GSK, comes as BioNTech is inching toward an ...

The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...